Am I eligible?

You may be eligible if you:

  • Live in the United States
  • Are at least 18 years of age or older
  • Are taking (or planning to take) Zeposia® (ozanimod) while breastfeeding for the treatment of multiple sclerosis or ulcerative colitis
  • Are willing to pump ALL of your breast milk for the 24 hours of breast milk collection during the second study visit (you will not be allowed to give any of the milk from this time to your baby)
  • Are not currently pregnant or planning to become pregnant during the study
  • Gave birth to a baby at 37 weeks or more gestation (term delivery) and your baby had a normal weight at the time of birth and currently has a normal weight.

Contact request form

Complete this form and a study team member will contact you with more information about participating in the study.

* marks required field

I authorize the Zinnia Lactation Study team to contact me and/or leave a message for me at these numbers or to contact me via email at the address listed below. I agree to the study team referencing the Zinnia Lactation Study in messages or emails.

The study is open from 8:30 am – 5:00 pm ET Monday-Friday

If you agree to take part, your study doctor will share your contact information securely with the VRCC team. Once you agree, VRCC will communicate with you related to scheduling of phone visits, home health visits and stipend coordination.

The VRCC study team member communicating with you may not be in the same country as you. Over-the-phone translation services will be available upon request. VRCC may reach out to you via SMS (text messaging), if you opt out of text messaging, this does not mean that you are opting out of any other communication. Text messaging will originate from PPD.

Yes, I wish to be enrolled in text messaging to receive important study information from the VRCC team during this study.

No, I do not wish to be enrolled in text messaging to receive important study information from the VRCC team during this study.

Privacy Statement:

Pharmaceutical Product Development, LLC. (PPD) respects your privacy and understands that it is important to you. The information you provide on this form will be used to contact you for the purposes of assessing your eligibility to participate in the Zinnia Lactation Study. This information will be held by PPD and not shared with the study sponsor (Bristol Myers Squibb) or any other third party without your permission. In the event you choose not to enroll, the study team will request permission to share your contact information with Propharma (a safety vendor hired by Bristol Myers Squibb), in order for them to contact you for safety follow up about your pregnancy. If you do not provide permission, and do not Enroll in the lactation study your contact details will be deleted.